# LFP Beta aDBS Feasibility Study

> **NCT03446833** · NA · TERMINATED · sponsor: **MedtronicNeuro** · enrollment: 1 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** The LFP Beta aDBS System

## Key facts

- **NCT ID:** NCT03446833
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-04
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03446833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03446833, "LFP Beta aDBS Feasibility Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03446833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*